Cardiac biomarkers area unit protein-based traceable substances used as an indicator of biological state for diagnostic and prognostic functions related to cardiac conditions. Commercialization of highly advanced and correct kind of cardiac biomarkers has provided a unique platform for identification of cardiac diseases. Continuous specialize in pipeline analysis and developments from leading players and raised patient awareness across untapped regions like Asian nation, China is essentially driving the expansion of cardiac biomarkers market.
The growing application of cardiac biomarkers as point of care (POC) testing facilitate fast ends up in chronic conditions, so drives the market growth. However, specificity and sensitivity connected issues of single measurement cardiac biomarkers, premium rating and bound government rules would hinder the market growth. Also, the market growth would bank on novel progress created in cardiac treatments using multi-assay biomarkers. The lifesaving advantages of those multi-assay biomarkers would foster the revenue generation method moreover as market penetration of novel cardiac biomarkers within the future.
The global cardiac biomarkers market estimated to worth US$ 7.6 Billion in 2019 is projected to reach US$ 16.40 Billion by 2028, growing a CAGR of around 9% in the given forecast period.
Market Insights
The global Cardiac Biomarkers market is segregated on the basis of Types as Creatine Kinase (CK-MB), Troponins (T, I), Myoglobin, Natriuretic peptides (BNP and NT-proBNP), Ischemia Modified Albumin, and Others. Based on Location of Testing the global Cardiac Biomarkers market is segmented in Point of care testing and Laboratory testing.
Based on Applications, the global Cardiac Biomarkers market is segmented in Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others.
The global Cardiac Biomarkers market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Cardiac Biomarkers market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Abbott laboratories, Alere Inc., Siemens Healthcare, Roche Diagnostics Corporation, Beckman Coulter, Becton, Dickinson And Co., Thermo Fisher Scientific, BioMerieux, Bio-Rad Laboratories, Randox laboratories, and others are among the major players in the global Cardiac Biomarkers market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Cardiac Biomarkers Market has been segmented as below:
Cardiac Biomarkers Market, By Types
Cardiac Biomarkers Market, By Location of Testing
Cardiac Biomarkers Market, By Applications
Cardiac Biomarkers Market, By Region
Cardiac Biomarkers Market, By Company
The report covers:
Report Scope:
The global Cardiac Biomarkers market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Cardiac Biomarkers market share. Major industry players with significant revenue share include Abbott laboratories, Alere Inc., Siemens Healthcare, Roche Diagnostics Corporation, Beckman Coulter, Becton, Dickinson And Co., Thermo Fisher Scientific, BioMerieux, Bio-Rad Laboratories, Randox laboratories, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Cardiac Biomarkers Market, By Types
5.1 Introduction
5.2 Creatine Kinase (CK-MB)
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Troponins (T, I)
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Myoglobin
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Natriuretic peptides (BNP and NT-proBNP)
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Ischemia Modified Albumin
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Others
5.7.1 Market Overview
5.7.2 Market Size and Forecast
6. Cardiac Biomarkers Market, By Location of Testing
6.1 Introduction
6.2 Point of care testing
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Laboratory testing
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Cardiac Biomarkers Market, By Applications
7.1 Introduction
7.2 Myocardial Infarction
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Congestive Heart Failure
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Acute Coronary Syndrome
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Atherosclerosis
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Others
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8. Cardiac Biomarkers Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Cardiac Biomarkers, By Types
8.2.2 North America Cardiac Biomarkers, By Location of Testing
8.2.3 North America Cardiac Biomarkers, By Applications
8.3 Europe
8.3.1 Europe Cardiac Biomarkers, By Types
8.3.2 Europe Cardiac Biomarkers, By Location of Testing
8.3.3 Europe Cardiac Biomarkers, By Applications
8.4 Asia-Pacific
8.4.1 Asia-Pacific Cardiac Biomarkers, By Types
8.4.2 Asia-Pacific Cardiac Biomarkers, By Location of Testing
8.4.3 Asia-Pacific Cardiac Biomarkers, By Applications
8.5 Rest of the World
8.5.1 Rest of the World Cardiac Biomarkers, By Types
8.5.2 Rest of the World Cardiac Biomarkers, By Location of Testing
8.5.3 Rest of the World Cardiac Biomarkers, By Applications
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Abbott laboratories
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Alere Inc.
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Siemens Healthcare
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Roche Diagnostics Corporation
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Beckman Coulter
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Becton, Dickinson And Co.
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Thermo Fisher Scientific
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 BioMerieux
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Bio-Rad Laboratories
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Randox laboratories
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Cardiac Biomarkers Market has been segmented as below:
Cardiac Biomarkers Market, By Types
Cardiac Biomarkers Market, By Location of Testing
Cardiac Biomarkers Market, By Applications
Cardiac Biomarkers Market, By Region
Cardiac Biomarkers Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
